false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Necrotizing Sweet Syndrome, a Not-So-Sweet Post-Op ...
Necrotizing Sweet Syndrome, a Not-So-Sweet Post-Operative Complication
Back to course
Pdf Summary
Necrotizing Sweet Syndrome (NSS), also called acute febrile neutrophilic dermatosis, is a rare inflammatory skin condition first described in 1964. It presents with fever, leukocytosis, and painful erythematous or edematous plaques, usually without active infection. NSS is uncommon, affects mostly women aged 30–60, and may be associated with autoimmune disease, malignancy, or be idiopathic. Because it can resemble necrotizing fasciitis, distinguishing the two is critical: fasciitis requires surgery and antibiotics, while NSS is treated primarily with corticosteroids. Misdiagnosis and unnecessary surgery can worsen NSS lesions.<br /><br />Diagnosis is based on clinical features and biopsy. Current criteria require two major and two minor findings. Histology is a major criterion, making biopsy essential, though diagnosis can be difficult because biopsy may not always show neutrophil predominance; lymphocytic or eosinophilic infiltrates can also occur. Epidermal sparing, spongiosis, ulceration, necrosis, and subcorneal pustules may be seen. Pathogenesis is not fully understood but likely involves immune and genetic factors.<br /><br />In the case presented, a 5-year-old boy developed worsening drainage, fever, and inflammation one week after bilateral hip replacement. He initially met sepsis criteria and was treated for possible infection with broad-spectrum antibiotics, but cultures were negative and symptoms persisted. Dermatology suspected neutrophilic dermatosis/NSS due to the postoperative setting, fever, leukocytosis, elevated ESR/CRP, and wound appearance. Biopsy showed ulceration, necrosis, marked acute inflammation, and spongiosis without neutrophilic predominance. High-dose prednisone led to clinical improvement, with decreased drainage and fever.<br /><br />First-line treatment for NSS is oral corticosteroids, typically prednisone 1 mg/kg/day or 40–60 mg, tapered over 4–6 weeks. Alternatives for steroid intolerance include colchicine or potassium iodide. Recurrent cases may require dapsone, indomethacin, clofazimine, cyclosporine, or potassium iodide.
Asset Subtitle
Mariam Ansar
Meta Tag
Author List
Aakhila Rameeza, Kathryn Haroldson, Kimberly Tena Diaz, Mariam Ansar
Category
Clinical Vignettes
Concept
Necrotizing Sweet Syndrome
Concept
Diagnostic Criteria
Concept
Systemic Corticosteroid
Concept
Acute Febrile Neutrophilic Dermatosis
Concept
Clinical Presentation
Distinguished
Non-Finalist
Presenter Organization
Cooper University Hospital
Presenting Author
Mariam Ansar
Track
Adult
Keywords
Necrotizing Sweet Syndrome
acute febrile neutrophilic dermatosis
corticosteroid treatment
necrotizing fasciitis differential
skin biopsy diagnosis
fever and leukocytosis
neutrophilic dermatosis
postoperative inflammation
prednisone therapy
autoimmune malignancy association
Necrotizing Sweet Syndrome
Diagnostic Criteria
Systemic Corticosteroid
Acute Febrile Neutrophilic Dermatosis
Clinical Presentation
×
Please select your language
1
English